Curated News
By: NewsRamp Editorial Staff
April 17, 2025
Nutriband CEO Gareth Sheridan Named Finalist in 2025 EY Entrepreneur of the Year Awards
TLDR
- Nutriband CEO Gareth Sheridan named finalist in 2025 EY Entrepreneur of the Year Awards, showcasing leadership in life sciences company development.
- Sheridan transforms Nutriband into U.S.-listed company focusing on transdermal drug delivery with AVERSA technology to prevent opioid patch abuse.
- AVERSA technology by Nutriband addresses critical gap in pain management by preventing misuse and abuse of opioid patches, making tomorrow's pain management safer.
- Finalists in EY program will compete for Entrepreneur of the Year title at gala event in November, showcasing outstanding Irish entrepreneurial leadership.
Impact - Why it Matters
This news highlights the recognition of Nutriband's CEO for his leadership in the pharmaceutical industry and the company's innovative approach to addressing opioid abuse. The development of abuse-deterrent technology like AVERSA showcases a commitment to patient safety and responsible pain management.
Summary
Nutriband CEO Gareth Sheridan named finalist in 2025 EY Entrepreneur of the Year Awards for leadership in transforming the company into a U.S.-listed life sciences company. The company's lead product, AVERSA, addresses opioid patch misuse.
Finalists will compete for the overall Entrepreneur of the Year title at a gala event in November. Nutriband focuses on developing transdermal pharmaceutical products, with AVERSA technology aimed at preventing drug abuse.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Nutriband CEO Gareth Sheridan Named Finalist in 2025 EY Entrepreneur of the Year Awards
